Cargando…

A Predictive Nomogram for Red Blood Cell Transfusion in Pheochromocytoma Surgery: A Study on Improving the Preoperative Management of Pheochromocytoma

PURPOSE: Surgery is the major treatment option for pheochromocytoma but carries potential risks, including hemorrhage and hemodynamic instability. Even with laparoscopic adrenalectomy, intraoperative blood transfusion happens from time to time, but few studies have investigated risk factors. For the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Guo, Ying, You, Lili, Hu, Huijun, Tong, Anli, Zhang, Xiaoyun, Yan, Li, Zhang, Shaoling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8006300/ https://www.ncbi.nlm.nih.gov/pubmed/33790869 http://dx.doi.org/10.3389/fendo.2021.647610

Ejemplares similares

Hemorrhage in pheochromocytoma surgery: evaluation of preoperative risk factors
por: Guo, Ying, et al.
Publicado: (2022)

Preoperative Management of Pheochromocytoma and Paraganglioma
por: Fang, Fang, et al.
Publicado: (2020)

Influence of duration of preoperative treatment with phenoxybenzamine and secretory phenotypes on perioperative hemodynamics and postoperative outcomes in pheochromocytoma and paraganglioma
por: Yao, Yao, et al.
Publicado: (2023)

A Nomogram for Predicting Intraoperative Hemodynamic Instability in Patients With Pheochromocytoma
por: Zhang, Zhiqiang, et al.
Publicado: (2022)

Mutational Profile and Potential Molecular Therapeutic Targets of Pheochromocytoma
por: Ma, Xiaosen, et al.
Publicado: (2022)

Genetic and Clinical Profiles of Pheochromocytoma and Paraganglioma: A Single Center Study
por: Ma, Xiaosen, et al.
Publicado: (2020)

Local-Regional Recurrence of Pheochromocytoma/Paraganglioma: Characteristics, Risk Factors and Outcomes
por: Cui, Yunying, et al.
Publicado: (2021)

Prognostic Nomograms for Predicting Overall Survival and Cancer‐Specific Survival of Patients With Malignant Pheochromocytoma and Paraganglioma
por: Zheng, Lei, et al.
Publicado: (2021)

Temozolomide Is a Potential Therapeutic Tool for Patients With Metastatic Pheochromocytoma/Paraganglioma—Case Report and Review of the Literature
por: Tong, Anli, et al.
Publicado: (2020)

Tumour microenvironment in pheochromocytoma and paraganglioma
por: Martinelli, Serena, et al.
Publicado: (2023)

Pheochromocytoma/paraganglioma-associated cardiomyopathy
por: Szatko, Alicja, et al.
Publicado: (2023)

A Novel Phenotype of Germline Pathogenic Variants in MAX: Concurrence of Pheochromocytoma and Ganglioneuroma in a Chinese Family and Literature Review
por: Chang, Xiaoyan, et al.
Publicado: (2020)

The Use of Telemedicine in the Preoperative Care of Pheochromocytoma: A Systematic Review
por: Alhazmi, Abdulhameed, et al.
Publicado: (2023)

Pheochromocytomas and Paragangliomas: Clinical and Genetic Approaches
por: Costa, Marcia Helena Soares, et al.
Publicado: (2015)

Pheochromocytomas and Paragangliomas as Causes of Endocrine Hypertension
por: Canu, Letizia, et al.
Publicado: (2019)

Hypoxia Signaling and Circadian Disruption in and by Pheochromocytoma
por: Tabebi, Mouna, et al.
Publicado: (2018)

Cancer Stem Cells in Pheochromocytoma and Paraganglioma
por: Scriba, Laura D., et al.
Publicado: (2020)

Editorial: Predictive tools in pheochromocytoma and paraganglioma
por: Ceccato, Filippo, et al.
Publicado: (2023)

Nomogram for predicting severe morbidity after pheochromocytoma surgery
por: Wang, Hongyan, et al.
Publicado: (2020)

Case Report: Pheochromocytoma and Synchronous Neuroblastoma in a Family With Hereditary Pheochromocytoma Associated With a MAX Deleterious Variant
por: Duarte, Diana Borges, et al.
Publicado: (2021)

Identification of Clinical Relevant Molecular Subtypes of Pheochromocytoma
por: Saddozai, Umair Ali Khan, et al.
Publicado: (2021)

The VHL/HIF Axis in the Development and Treatment of Pheochromocytoma/Paraganglioma
por: Peng, Song, et al.
Publicado: (2020)

Surgical strategies of complicated pheochromocytomas/paragangliomas and literature review
por: Wang, Xu, et al.
Publicado: (2023)

Clinical differences between small and large pheochromocytomas and paragangliomas
por: Zhao, Lin, et al.
Publicado: (2023)

Histopathological Analysis of Tumor Microenvironment and Angiogenesis in Pheochromocytoma
por: Gao, Xin, et al.
Publicado: (2020)

Update of Pheochromocytoma Syndromes: Genetics, Biochemical Evaluation, and Imaging
por: Alrezk, Rami, et al.
Publicado: (2018)

Case Report: An Unusual First Manifestation of a Pheochromocytoma
por: Zhai, Qiangrong, et al.
Publicado: (2021)

Adrenal bleeding due to pheochromocytoma - A call for algorithm
por: Rzepka, Ewelina, et al.
Publicado: (2022)

Glycemic Disturbances in Pheochromocytoma and Paraganglioma
por: Ronen, Joshua A, et al.
Publicado: (2019)

Pheochromocytoma Crisis in the Emergency Department
por: Bartikoski, Stephanie R, et al.
Publicado: (2021)

Pheochromocytoma: A Case Report
por: Antunes, Eulália, et al.
Publicado: (2022)

Pheochromocytoma in an Ectopic Adrenal Gland
por: Wahbi, Salma, et al.
Publicado: (2023)

A Predictive Nomogram for Early Death in Pheochromocytoma and Paraganglioma
por: Li, Huiyang, et al.
Publicado: (2022)

Preoperative risk factors for massive blood loss in adrenalectomy for pheochromocytoma
por: Liu, Hongju, et al.
Publicado: (2017)

Preoperative blood pressure targets and effect on hemodynamics in pheochromocytoma and paraganglioma
por: Ugleholdt, Randi, et al.
Publicado: (2022)

SDHB immunohistochemistry for prognosis of pheochromocytoma and paraganglioma: A retrospective and prospective analysis
por: Su, Tingwei, et al.
Publicado: (2023)

Predictive Factors for Catecholamine-Induced Cardiomyopathy in Patients with Pheochromocytoma and Paraganglioma
por: Wang, Yi, et al.
Publicado: (2022)

Factors contributing to development and resolution of dysglycemia in patients with pheochromocytomas and catecholamine-secreting paragangliomas
por: Zhao, Lin, et al.
Publicado: (2023)

Noradrenergic Pheochromocytoma: A Case Report
por: Essafi, Mohammed Amine, et al.
Publicado: (2022)

Promoter Methylation Status of Ras-Association Domain Family Members in Pheochromocytoma
por: Richter, Antje M., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_kbea1hdtbc5hjtqppaf6ct7e5c